The 16 analysts offering 1 year price forecasts for HIMS have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to HIMS in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
HIMS EPS for the last quarter is 0.10 CHF despite the estimation of 0.10 CHF. In the next quarter EPS is expected to reach 0.10 CHF. Track more of HIMS & HERS HEALTH financials and stay on top of what is up with the company.
In the next quarter HIMS & HERS HEALTH revenue is expected to reach 473.55 M CHF. Check out HIMS & HERS HEALTH revenue and earnings and make informed decisions.
According to analysts, HIMS price target is 40.38 CHF with a max estimate of 74.81 CHF and a min estimate of 18.48 CHF. Check if this forecast comes true in a year, meanwhile watch HIMS & HERS HEALTH stock price chart and keep track of the current situation with HIMS news and stock market news.
We've gathered opinions of 17 analysts rating HIMS stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.